Blue Horseshoe Stocks: Cannabis Stock Resurgence

Marijuana Stocks Making a Comeback

The biggest standout of yesterday’s session was the unmistakable resurgence of the cannabis sector. Many of you will recall that we have tracked this sector throughout the year, and indeed, dating much further back than that. The gains we’ve seen from this market in 2014 have been nothing short of historical. Over the past few months, however, we had been witnessing a huge beatback sector-wide, with pot plays steadily declining across the board.

You can see below from the random chart examples we’ve pulled, that similar action has been occuring in most every related stock. Familiar plays like HEMP, TRTC, and GRNH all exhibit strikingly similar paths. Steady, heavy losses followed by distinct signs of a turnaround.

Presumably the pickup we’re seeing as we head into the end into week’s end is due at least in part to campaign season kicking off for proponents of cannabis in places like Alaska, Florida, Oregon and Washington, D.C, who will all be voting on marijuana initiatives in some form or other on November 4th.

Other states are sure to be paying attention, especially those that are tight on cash. Colorado estimates that tax revenues from its first year of recreational sales stand at $60-70M. Meanwhile, Washington State’s measure roll-out of retail sales continues slowly, with only the second Seattle marijuana outlet scheduled to open up next Tuesday.  In a study conducted by NerdWallet.com, the nationwide legalization of pot would produce over $3B annually.

So here we are, having waited patiently for the marijuana space to begin to heat up again, finally seeing the kind of rebound activity that can provide us with quick in-and-out gains. We’re going to want to watch anything even remotely tied to the industry as voting time draws even closer.


Extended Watchlist:
RPRX, CNET, NAVB, DRYS, GALE

Blue Horseshoe Stocks: ACHN, PBR & Extended Watchlist

Petroleo Brasiliero S.A. (Petrobras) PBR

PBR had another solid day yesterday, dipping below $15 only briefly where it found support at 14.88 before going on to push its upper limits over the course of the session, acvhieving a new high for us at 15.34.

All of the options contracts that we’ve been monitoring on PBR served up chances to gain a significant amount as the stock continued to bull its way north.

Even our longer-term idea, the 07/19 $15 Calls we’ve been tracking since last week from a low of .25 has already given us the triple-bagger we suggested it might in last Wednesday’s report. They closed out the day at .88, an overall move of 252% and it would appear they want to gap up along with PBR stock this morning, so we expect that figure to increase even further.

PBR has come a long way since we caught it coming off of 10-year lows back on March 21st. The stock itself has regained a lot of ground, coming from our observed low of 11.25 all the way up to current levels above $15. As we stated yesterday, if PBR has a tough time breaking through resistance at its previous swing high of 15.85, we’ll start to think about taking profits off of the table.


Achillion Pharmaceuticals, Inc. ACHN

We have to begin this morning by congratulating any of our readers who picked up on our coverage of ACHN yesterday, which allowed us the chance to make sizable gains for the second day in a row.

The stock gapped up as it did on Monday and continued to roll, trading in a range from 6.02 to 7.81 on the day, giving traders the opportunity to pocket close to 30% in profits intraday on inordinately high volume (To the tune of more than 22x the 3-month average).

From the low of 3.72 that we observed on Monday, the stock has already made a fantastic  110% move to the upside over the span of just two sessions.

The company put more news out this morning as well:

NEW HAVEN, Jun 11, 2014 (GLOBE NEWSWIRE via COMTEX) — Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that members of the senior management team will present a corporate overview at two upcoming investor conferences:– 2014 Wells Fargo Healthcare Conference on Wednesday, June 18, 2014 at 1:15 p.m. ET at the InterContinental Hotel in Boston, MA; and– JMP Health Care Conference 2014 on Tuesday, June 24, 2014 at 11:00 a.m. ET at the Westin New York Grand Central Hotel in New York, NY.

The live audio and subsequent archived webcasts of the Company’s presentations will be accessible from the Company’s investor relations website, http://ir.achillion.com.


Extended Watchlist:
NWBO, NAVB, BIOF, PEIX, END, XXII

Blue Horseshoe Afternoon Updates

For the second day in a row, performances from the subjects of our morning report have necessitated an afternoon follow-up. We managed to pile up several chances for big gains, even with the temporary glitch that left OTC trading halted for roughly an hour around lunchtime. It was the second such outage in the past month.


BG Medicine, Inc. BGMD

BGMD leads the way, with an excellent showing this morning. After seeing a low of .6115, the stock streaked upward and went on to hit highs in the 1.20’s. Gains approaching 100% have been possible thus far as BGMD has reached its highest levels since August.


Tiger Oil & Energy, Inc. TGRO

TGRO continued its uptrend this morning, topping out at .635. That marks a possible gain of 32% from today’s low, and a whopping 76% from Monday’s low following our initial alert.


Rambus, Inc. RMBS

RMBS was yet another winner this morning, coming off of our extended watchlist and powering its way to a 28% intraday gain from 8.25 to 10.57.


Navidea Biopharmaceuticals, Inc. NAVB

We put NAVB on our radars this morning after it popped up on our news feed, and has put up a solid move of 16%, with a daily range from 1.90-2.20.


Not signed up for our daily pre-market alerts yet? CLICK HERE and get your free subscription today!